Carole Ho, Chief Medical Officer at Denali Therapeutics Inc. (DNLI), sold 1,476 shares at $29.40 ($43K) on 2023-02-15, disclosed to the SEC on 2023-02-17.
Scheduled sale ($43k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| DNLI | SELL | 2024-08-22 | $1.1M | — | Filing → |
| DNLI | SELL | 2024-08-15 | $107K | — | Filing → |
| DNLI | SELL | 2024-02-15 | $73K | — | Filing → |